Literature DB >> 15491713

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

Ichiya Honma1, Naoya Masumori, Eiji Sato, Akio Takayanagi, Atsushi Takahashi, Naoki Itoh, Mitsuharu Tamagawa, Masa-aki Sato, Taiji Tsukamoto.   

Abstract

OBJECTIVES: To examine which clinicopathologic parameters predict clinically detectable local recurrence after radical cystectomy. Local recurrence after radical cystectomy for invasive bladder cancer was infrequently observed until 20 years ago because of the lack of adequate diagnostic tools. The recent development and use of pelvic computed tomography has allowed us to detect local recurrence more precisely. However, only a few studies have investigated the rate and pattern of local recurrence in the computed tomography era.
METHODS: This retrospective review included 145 patients with muscle-invasive bladder cancer treated with radical cystectomy, regional pelvic lymph node dissection, and urinary diversion between January 1990 and December 2001. The development of local recurrence and/or distant metastasis was analyzed as the endpoint using univariate and multivariate analyses.
RESULTS: Local recurrence developed in 27 (18.6%) of the 145 patients at a median of 8 months after cystectomy. Of the 27 patients, 8 had local recurrence alone and 19 had concurrent distant metastasis. Distant metastasis without local recurrence developed in 34 patients (23.4%). Univariate and multivariate analyses revealed that Stage pT3-T4 and pathologic pelvic lymph node involvement were statistically significant factors predicting clinical failure, local recurrence, and/or distant metastasis. However, a concomitant squamous cell carcinoma component in the specimen was the only independent predictor of local recurrence alone in both univariate and multivariate analyses.
CONCLUSIONS: Only the finding of a concomitant squamous cell carcinoma component in the specimen was an independent predictor of local recurrence in patients treated with radical cystectomy.

Entities:  

Mesh:

Year:  2004        PMID: 15491713     DOI: 10.1016/j.urology.2004.05.003

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  38 in total

1.  Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.

Authors:  Ken-ichi Harada; Iori Sakai; Toshifumi Kurahashi; Mototsugu Muramaki; Kazuki Yamanaka; Isao Hara; Hiroshi Eto; Hideaki Miyake
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?

Authors:  S Machele Donat
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Authors:  Asaf Wyszynski; Sam A Tanyos; Judy R Rees; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Eben M Pendleton; Maria O Celaya; Michael S Zens; Margaret R Karagas; Angeline S Andrew
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

4.  Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Vladimir Novotny; Michael Froehner; Matthias May; Chris Protzel; Katrin Hergenröther; Michael Rink; Felix K Chun; Margit Fisch; Florian Roghmann; Rein-Jüri Palisaar; Joachim Noldus; Michael Gierth; Hans-Martin Fritsche; Maximilian Burger; Danijel Sikic; Bastian Keck; Bernd Wullich; Philipp Nuhn; Alexander Buchner; Christian G Stief; Stefan Vallo; Georg Bartsch; Axel Haferkamp; Patrick J Bastian; Oliver W Hakenberg; Stefan Propping; Atiqullah Aziz
Journal:  World J Urol       Date:  2015-02-08       Impact factor: 4.226

5.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.

Authors:  Antonio Lopez-Beltran; Maria J Requena; Jose Alvarez-Kindelan; Ana Quintero; Ana Blanca; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

6.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis.

Authors:  Angeline S Andrew; Margaret R Karagas; Florian R Schroeck; Carmen J Marsit; Alan R Schned; Jason R Pettus; David A Armstrong; John D Seigne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

8.  Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.

Authors:  Shigeru Sakano; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Yoshikazu Baba; Tomoyuki Shimabukuro; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; Kazuo Oba
Journal:  Int J Clin Oncol       Date:  2014-06-27       Impact factor: 3.402

9.  Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration.

Authors:  Douglas W Strand; David J DeGraff; Ming Jiang; Mansoureh Sameni; Omar E Franco; Harold D Love; William J Hayward; Opal Lin-Tsai; Anne Y Wang; Justin M M Cates; Bonnie F Sloane; Robert J Matusik; Simon W Hayward
Journal:  Am J Pathol       Date:  2012-12-06       Impact factor: 4.307

Review 10.  Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting.

Authors:  Andrea B Apolo; Herbert Barton Grossman; Dean Bajorin; Gary Steinberg; Ashish M Kamat
Journal:  Urol Oncol       Date:  2012 Nov-Dec       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.